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Podocytes that detach in experimental membranous nephrop-
athy are viable.
Background. Podocyte loss contributes to the development
of glomerulosclerosis. Although podocytes have been detected
in the urine in certain glomerular diseases, the viability of
detached cells is not known.
Methods. Urine was collected from rats with experimental
membranous nephropathy [passive Heymann nephritis (PHN)
model], centrifuged, and following resuspension in tissue cul-
ture media, cells were seeded onto collagen-coated tissue cul-
ture plates. Cells were grown under typical cell culture condi-
tions. Cell number was measured, the cell type was identified
by immunostaining with specific antibodies, and cell morphol-
ogy was assessed by light and electron microscopy.
Results. Cells obtained in the urine from PHN rats were pos-
itive for synaptopodin, nephrin, podocin, WT-1, and GLEPP1
(podocyte-specific antigens). When grown ex vivo under cell
culture conditions, cells obtained in the urine from PHN rats ad-
hered to tissue culture plates, and expressed podocyte-specific
proteins at the mRNA [reverse transcription-polymerase chain
reaction (RT-PCR)] and protein (immunostaining) level. Cells
did not stain with antibodies to mesangial (OX-7), tubular
(Tamm-Horsfall protein) and endothelial (RECA) cells. Elec-
tron microscopy showed the presence of foot processes, and
podocytes from PHN rats stained positive for C5b-9. Although
podocyte number increased transiently during the first 5 days
ex vivo, apoptosis increased significantly thereafter, reducing
overall cell number.
Conclusion. Rats with experimental membranous nephrop-
athy shed podocytes into the urine that attach to tissue culture
plates ex-vivo, and proliferate. These results suggest that de-
tached podocytes are viable. These results add new perspec-
tives into our understanding of podocyte loss in the develop-
ment of glomerulosclerosis.
Podocytes, also called visceral glomerular epithelial
cells, are terminally differentiated and highly specialized
1See Editorial by Mundel, p. 1529.
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cells lining the outer aspect of the glomerular basement
membrane [1, 2]. It has been well established that a
decrease in podocyte number contributes to the develop-
ment of glomerulosclerosis in most forms of nephrotic
syndrome. However, it is not clear why podocyte num-
ber decreases in immune-mediated disease such as mem-
branous nephropathy, or in nonimmune diseases such
as diabetic nephropathy [3–5]. One explanation is that
podocytes are unable to proliferate and replace those lost,
because they are terminally differentiated [6, 7]. Another
possibility is podocyte apoptosis, which has been shown
in experimental and human glomerular diseases [8–11].
A third plausible mechanism underlying podocyte loss
is detachment of cells from the glomerular basement
membrane. Indeed, studies have shown that podocytes
are present in the urine of patients with a variety of glo-
merular diseases [12–18].
However, it is unclear if podocytes in the urine are
viable and biologically active, or if detached podocytes
are nonviable. Accordingly, the goal of this study was
to determine the viability of podocytes that detach in
experimental membranous nephropathy. Our data show
that podocytes present in the urine are viable, have the
ability to attach to tissue culture plates ex vivo, and have
a limited proliferative capacity.
METHODS
Passive Heymann nephritis (PHN) model
To determine if viable podocytes detach from the glo-
merular basement membrane following complement
(C5b-9)-mediated injury, the passive Heymann nephritis
(PHN) model of experimental membranous nephropa-
thy was induced in male Sprague-Dawley rats (Simson;
Gilroy, CA, USA) weighing 180 to 200 g by intraperito-
neal injection of sheep antibody to Fx1A (5 mL/kg body
weight) as previously described [7]. Control animals were
injected with normal sheep serum. A 24-hour urine col-
lection was performed on control and PHN rats prior to
sacrifice, and urine protein excretion was determined by
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the sulphosalicylic method as previously reported [19].
Urine collected by this method was used to isolate cells
in the urine (see below). Urine was also obtained by
bladder puncture (see below) from PHN and control
animals on days 1, 3, 5, 6, 10, and 20 (N  6 per group/
time point). At sacrifice, renal biopsies were taken from
control and PHN rats.
Urine collection and cell culture
In order to collect urine from individual control and
diseased rats by bladder puncture, animals were anesthe-
tized by ether inhalation and an intramuscular injection
of a mixture containing ketamine (50%), xylazine (25%),
and acepromazine (15%) in Ringer’s solution (10%).
Following anesthesia, a butterfly needle was inserted into
the tail vein, and a bolus of 6 to 8 mL of normal saline
was injected intravenously, over 2 to 5 minutes, to induce
a forced diuresis leading to immediate and predictable
bladder filling. Our pilot studies showed that cells were
also detected in urine collected for 12 hours and 24 hours
in animals that did not receive saline. However, using timed
collections, urine volumes were significantly smaller, and
at times, undetectable. Moreover, collecting urine for 12
hours and 24 hours was also hampered by the co-collec-
tion of feces and dander. Accordingly, to ensure that we
could predictably collect adequate urine that was not
contaminated, all control and diseased animals in this
study received saline boluses at each time point studied.
Following the administration of intravenous fluid, the
abdomen was shaved and opened through a longitudinal
incision. The urinary bladder was localized, and a sterile
insulin syringe was used to puncture the bladder. Urine
(0.8 to 1 mL) was removed by syringe, and rapidly trans-
ferred to a sterile 12 mL tube. The urine acidity was par-
tially neutralized by adding 11 mL of prewarmed Hanks’
solution. Following centrifugation at 1200 rpm at room
temperature for 5 minutes, the supernatant was removed
by careful suction and discarded, and the cell pellet resus-
pended in 12 mL of cell culture Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS) (Summit Biotechnology, Ft. Collins, CO,
USA), penicillin (100 U/mL), streptomycin (100 U/mL),
and glutamine (2 mmol/L) (Irvine Scientific, Santa Ana,
CA, USA). This medium is used to culture rat podocytes
in vitro. The resuspended pellet was divided into 2 mL
aliquots and seeded in individual wells in a six-well tissue
culture plate (Nunclon; Denmark) coated with collagen I
(BD Biosciences; Two Oak Park, MA, USA). Tissue
culture plates were incubated at 37C in 95% air/5%
CO2 overnight. The following day, red blood cells and
nonattached cells were removed by washing with Hanks’
solution. Adherent cells were subsequently grown at
37C in DMEM medium containing 5% FBS, which was
replaced every 3 days.
Documentation of cell attachment
After 24 hours of cell culture, cells that formed “colo-
nies” (defined as five adherent cells that were making
cell-cell contact) were marked by circling the base of the
tissue culture plate. Twice-daily inverted microscopy was
performed to count the number of adherent cells within
each colony and to document morphologic changes. Cells
with typical apoptotic morphologic features were also
counted, as we have reported previously [20].
Immunostaining
In vivo. In PHN rats, detection of sheep immunoglob-
ulin G (IgG) and C5b-9 in glomeruli was performed by
direct (sheep IgG) and indirect (C5b-9) immunofluores-
cent staining on 4 m frozen renal biopsy sections fixed
in ether/alcohol as described elsewhere [7]. Sections were
stained with fluorescein conjugated rabbit antisheep IgG
(Organon Teknika Corporation, West Chester, PA, USA)
or biotinylated 2A1, a murine monoclonal antibody to rat
C5b-9, followed by fluorescein-conjugated streptavidin
(Amersham, Arlington Heights, IL, USA). Tissue sec-
tions fixed in methyl carnoys solution were also used for
periodic acid-Schiff (PAS) staining.
Immunofluorescent staining of cultured cells. The cell
type growing ex vivo on tissue culture plates from control
and membranous rats was determined by immunofluo-
rescent staining at day 1 and day 8 after seeding. Adher-
ent cells were fixed at –20C in methanol:acetone (1:1)
for 20 minutes, air dried for 15 minutes, rehydrated with
phosphate-buffered saline (PBS), and permeabilized with
0.1% NP40. Cells were incubated overnight at 4C with
the following podocyte-specific antibodies: (1) WT-1
(mouse monoclonal; clone sc-7385) (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) (1:100 dilution); (2) sy-
naptopodin (mouse monoclonal; clone G1) (gift of Dr.
Peter Mundel, Albert Einstein, Bronx, NY) (1:20 dilu-
tion); (3) nephrin (rabbit polyclonal) (gift of Dr. Harry
Holtho¨fer, University of Helsinki, Helsinki, Finland)
(1:100 dilution); (4) GLEPP1 (rabbit polyclonal) (gift of
Dr. Roger Wiggins, University of Michigan, Ann Arbor,
MI) (1:5 dilution); and (5) podocin (rabbit polyclonal)
(gift of Dr. Peter Mundel, Albert Einstein, Bronx, NY)
(1:50 dilution).
To determine if cells other than podocytes were grow-
ing ex vivo, immunostaining was also performed with
antibodies to (1) Thy1.1, a mesangial cell specific antigen
(clone MRC OX-7) (Serotec, Ltd., Oxford, England);
(2) RECA-1, an endothelial cell-specific antibody (clone
HIS52) (Serotec Ltd.); (3) Tamm-Horsfall protein, spe-
cific for thick ascending limb (gift of Dr. J. Hoyer,
Department of Pediatrics, University of Pennsylvania,
Philadelphia, PA, USA) [21]; and (4) a fluorescein iso-
thiocyanate (FITC)-labeled lectin from Tetragonolobus
purpureas, specific for proximal tubular cells (Sigma Chem-
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ical Co., St. Louis, MO, USA) [22]. We tested the speci-
ficity of all the antibodies on frozen kidney sections by
immunoflourescence as described above for cultured cells.
A secondary biotinylated horse antimouse (clone BA-
1000) (Vector Laboratories, Burlingame, CA, USA) (1:100
dilution) or goat anti-rabbit (clone BA-2001) (Vector Lab-
oratories) (1:200 dilution) antibody was used, followed by a
fluorescein-conjugated streptavidin antibody (Amersham).
To determine the presence of C5b-9 on detached cells,
and to determine if podocytes were present in the urine
obtained by cytospin prior to growing ex vivo, urinary
cells from control and PHN rats (day 5) were fixed for
20 minutes in methanol:acetone (1:1) at20C, air dried
for 15 minutes, rehydrated with PBS, and stained with
a biotinylated primary antibody directed against C5b-9
over night (1:50 dilution), which had been successfully
used in the staining of frozen tissue from PHN day 5
rats in the past. A secondary staining with streptavidin-
fluorescein (RPN 1232) (Amersham) (1:100 dilution) for
30 minutes at room temperature was performed. These
cells were also immunostained with antibodies directed
against WT-1, GLEPP1, and nephrin.
Finally, to determine if podocyte number decreases in
PHN rats, WT-1 indirect immunoperoxidase immuno-
staining was performed on biopsies from control and
PHN rats as previously reported [23]. The number of
WT-1 staining cells (i.e., podocytes) in 20 to 50 glomeruli
were counted in individual control and PHN rats (N 
6/time point/group) at 1, 2, 3, 4, and 6 months. In order to
correlate podocyte number with proteinuria, regression
analysis was performed. Regression analysis was also
performed to correlate the number of podocytes in the
urine and proteinuria on day 5.
Electron microscopy. Scanning electron microscopy
was also performed on adherent cells fixed in half-
strength Karnovsky’s solution after 8 days in cell culture.
Methods for reverse transcription-polymerase chain
reaction (RT-PCR)
In order to ensure that the immunostaining results
were confirmed at the mRNA level, we performed RT-
PCR on RNA obtained from cells in the urine of control
and PHN rats and on RNA obtained from adherent cells
grown under cell culture conditions. Total RNA was iso-
lated from cells immediately after collection from the
urine of individual rats, and on day 2 growing in culture
ex vivo, using Tri Reagent (Sigma Chemical Co.) ac-
cording to the manufacturer’s instructions. RQ1 RNase-
free DNase (Promega, Madison, WI, USA) was used to
remove genomic DNA. cDNA synthesis was carried out
with SuperScript First-Strand Synthesis System (Life
Technologies, Gibco BRL, Rockville, MD, USA) ac-
cording to the manufacturer’s instructions. Negative con-
trol PCR reactions used samples that did not have re-
verse transcriptase added to the first strand synthesis
reaction or H2O added instead of cDNA. Alternatively,
RNA samples were treated with RNase-free DNase be-
fore the first-strand synthesis. Total RNA from normal
whole rat kidney was used as a positive control.
PCR for WT-1 was performed with sense primer 5-gtc
ctcccccgcccagccag-3 and antisense primer 5-tgtagggcgtcc
tcaggagc-3. PCR conditions were a MgCl2 concentration
of 2.25 mmol/L, 35 to 40 cycles with 45 seconds at 95C,
45 seconds at 66C, 1 minute at 72C, followed by 10
minutes at 72C. Nephrin sense primer was 5-gttcagctg
ggagagactgg-3 and antisense primer 5-aatcggacgacaag
acgaac-3. Podocin sense primer was 5-tctcccaaacctgttga
acc-3 and antisense primer was 5-gcgtgtgtccatcttgtgac-3.
For nephrin and podocin, PCR conditions were 2 mmol/L
MgCl2, 35 to 40 cycles with 45 seconds at 94C, 45 seconds
at 55C, 1 minute at 72C, followed by 10 minutes at 72C.
For PCR of synaptopodin sense primer was 5-gcagag
gaagtgaggtccag-3 and antisense primer was 5-gatgccac
tagggtgctagg-3 with 2 mmol/L MgCl2 and for PCR of
GLEPP1 sense primer was 5-atggttcagtcggctctttg-3 and
antisense primer was 5-tcaccgagtcttcctgtgtg-3 with 1.5
mmol/L MgCl2 were used. Synaptopodin and GLEPP1
PCR conditions were 40 cycles with 45 seconds at 94C,
45 seconds at 57C, 1 minute at 72C, followed by 10
minutes at 72C. All PCR reactions used Taq DNA Poly-
merase (Promega).
RESULTS
Cells isolated from the urine of PHN rats
are podocytes
As expected, urinary protein increased in PHN rats,
but not in control rats injected with normal sheep serum
(Fig. 1A). To test the hypothesis that podocytes detach
from the glomerular basement membrane in PHN rats,
immunostaining and RT-PCR was performed for podo-
cyte-specific antigens on cells obtained in the urine from
control and PHN rats. One of the anticipated problems
with the standard 12-hour or 24-hour urine collection is
that if any viable cells were present, they might die at
room temperature or if left unattended. Also, the urine
collected over 24 hours is often contaminated by feces
and dander, and cells are exposed to a low pH. Accord-
ingly, to reliably obtain urine from rats, and to ensure
that viability was not compromised, control and diseased
animals were injected with a volume of saline intrave-
nously that did not cause any cardiovascular compromise
or fluid overload. To exclude an increase in Starling
forces underlying the detachment of podocytes from the
glomerular basement membrane, these experiments were
repeated at least three times, and control rats (injected
with normal sheep serum) and healthy normal rats were
also injected with saline. Please note that the results
described below were identical when obtained using the
“standard” 12-hour or 24-hour urine collection. Also
Petermann et al: Detached urinary podocytes are viable 1225
Fig. 1. Proteinuria and cell number in passive Heymann nephritis
(PHN). (A ) There was a sustained increase in 24-hour urinary protein
excretion in PHN rats at each time point studied compared to control
rats injected with normal sheep serum. *P  0.001 vs. control (values
represent mean standard errors). (B ) Podocyte number was measured
by counting the number of WT-1–positive cells. Podocyte number de-
creased in PHN rats, but not in controls. *P  0.001 vs. control. (C )
There was a significant correlation between proteinuria and the decrease
in podocyte number in PHN rats.
note that sacrificed PHN rats who did not receive saline
had viable cells in the urine. In contrast, no cells were
present in healthy controls using the same method.
Figure 2 shows that when the urine obtained from
Fig. 2. Immunostaining for podocyte antigens in the urine of passive
Heymann nephritis (PHN) rats. Immunostaining was not detected when
the primary antibody was omitted, which was used as a negative control
(A ). Immunostaining for WT-1 (B ), nephrin (C ), and GLEPP1 (D ),
podocyte-specific antigens, was detected in cells obtained from the urine
of PHN rats, but not from controls (not shown). Double immunostaining
for Hoechst and C5b-9 (E ) and (F ), respectively, in cells in the urine
from PHN rats show that detached cells stain positive for C5b-9.
PHN rats was centrifuged, the collected cells stained
positive for WT-1, nephrin, and podocin. GLEPP1 stain-
ing was also detected (results not shown). Immunostain-
ing for these podocyte-specific antigens was not detected
in urine from control rats. Immunostaining for synapto-
podin was not detected in PHN rats (data not shown).
This result was not a false negative because we showed
by immunostaining that these antigens were detected in
glomeruli of control and PHN rats (data not shown).
Because of the low protein yield from cells in the
urine, the mRNA levels for podocyte-specific antigens
were measured by RT-PCR instead of Western blot anal-
ysis. Figure 3 shows that mRNA expression for WT-1,
GLEPP1, nephrin, podocin, and synaptopodin was de-
tected in cells obtained from the urine of PHN rats. A
housekeeping mRNA was not performed because these
results were not quantitative, but rather were performed
to determine the presence of transcripts. Taken together,
these results show that podocytes were detected in the
urine from PHN rats (results summarized in Table 1).
Podocyte number decreases in PHN rats
We next asked if the presence of podocytes in the
urine leads to a decrease in podocyte number in PHN
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Fig. 3. Reverse transcription-polymerase chain
reaction (RT-PCR) for podocyte antigens in
the urine of passive Heymann nephritis (PHN).
Total RNA was extracted from the cells obtained
in the urine of PHN rats, and subjected to RT-
PCR. mRNA expression for WT-1, GLEPP1,
nephrin, podocin and synaptopodin (synapo)
was detected. RNA from rat kidneys served
as positive controls, and replacing the RT mix
with H2O served as negative control.
Table 1. Summary of the expression of podocyte-specific proteins in cells obtained from the urine of
passive Heymann nephritis (PHN) rats
WT-1 Nephrin Podocin GLEPP1 Synaptopodin
Staining of nonadherent urinary cells 	 	 	 	 
RT-PCR of nonadherent urinary cells 	 	 	 	 	
Staining of adherent cells  	 	 	 	
RT-PCR of adherent cells 	  	 	 
RT-PCR is reverse transcription-polymerase chain reaction. 	, expression detected; , expression not detected.
rats. Accordingly, we counted the number of cells stain-
ing positive for WT-1 in control and PHN rats at different
time points. Figure 1B shows that podocyte number de-
creased progressively in PHN rats, and this reached sta-
tistical significance by 2 months of disease (P  0.001
vs. control; P  0.001 vs. normal rat). Podocyte number
did not decrease in control rats injected with normal
sheep serum.
In order to determine any correlation between podo-
cyte number and proteinuria, regression analysis was
performed, and the data are shown in Figure 1C. There
was a statistically significant correlation between
WT-1–positive cells per glomerulus (i.e., podocytes) and
urine protein in PHN rats (R2  0.986). Taken together,
podocyte number decreases in PHN rats, and this corre-
lates with an increase in proteinuria.
Podocytes in the urine of PHN rats are viable
In order to determine if podocytes detected in the
urine of PHN rats were viable, urine collected from con-
trol and PHN rats was centrifuged, resuspended in tissue
culture media, plated out onto tissue culture plates, and
maintained under standard tissue culture conditions. No
cells were detected growing in cell culture plates ob-
tained from normal rats, or from control rats injected
with normal sheep serum. In contrast, Figure 4 shows
that when cells were obtained from the urine of PHN
rats and grown in culture, cells were easily identified that
were adherent to tissue culture plates within 4 hours of
plating. Adherent cells were either single, in clusters
of five cells, or in “colonies” comprising more than ten
cells. Figure 4 shows typical “colonies” of cells in culture
after 24 hours of growth. When followed serially over
time, it was observed that single cells had moved from
their original location to join a “colony” of cells, sug-
gesting that they were motile. Motility can also be seen
in Figure 4A and B with cells spreading out centrifugally
in all directions from the colony center to the periphery.
Figure 4C and D also shows that the number of individual
cells within a “colony” increased. Individual cells also
increased in size over time. Taken together, viable cells
(adherent, motile, and increasing in number) were pres-
ent in urine from PHN rats, and not in controls.
In order to determine if viable cells were detected in
the urine at different times following the induction of
PHN, and to determine the peak of this event, urine was
collected at different time points following the induction
of experimental membranous nephropathy, and in con-
trol rats receiving normal sheep serum. At each time
point, the number of adherent cells were quantitated
after growing ex vivo for 24 hours under cell culture
conditions. Figure 5 shows that cells were not detected
in control rats injected with normal sheep serum. In PHN
rats at days 1 and 3, the number of cells adherent to
tissue culture plates was not significantly increased com-
pared to control rats (Fig. 5). However, there was a
marked and significant increase in cells when urine was
collected from PHN rats at day 5 (P 0.001 vs. control).
The peak number of cells obtained from the urine from
PHN rats that were adherent to cell culture plates was
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Fig. 4. Cells obtained from the urine of passive Heymann nephritis
(PHN) rats grow under cell culture conditions. Cells obtained form the
urine of PHN rats were resuspended in tissue culture medium, and
grown under cell culture conditions. Cells obtained from the urine of
three different PHN animals adhered to tissue culture plates at 24 hours
ex vivo (A, C, and E ). Cells have a typical cobblestone appearance.
The same cells at 48 hours ex vivo (taken at the same magnification),
and illustrate an increase in cell number, cell size, and mobility (B, D,
and F ).
Fig. 5. Podocytes were detected in the urine of passive Heymann ne-
phritis (PHN) rats at numerous time points. Urine was collected at
different time points from PHN rats (N  6 each time point), grown
under cell culture conditions ex vivo, and total cell number was mea-
sured after 24 hours in cell culture on the adherent cells. Although cells
were present at day 3, the increase was not statistically significant
compared to control. There was a progressive and significant increase
in cells obtained from the urine of PHN rats when grown ex vivo, with
a peak in animals at day 6 of disease. Although the number declined
at days 10 and 20 of disease, the number of cells remained statistically
significantly compared to control rats injected with normal sheep serum.
*P  0.01 vs. control.
Fig. 6. Cells growing ex vivo stain positive for podocyte-specific mark-
ers. Cells obtained from the urine of passive Heymann nephritis (PHN)
rats that adhered and grew on tissue culture plates ex vivo stained
strongly positive for (A ) podocin, (B ) nephrin, GLEPP1 (C ) and
stained weakly for synaptopodin (D ). These results show that cells are
podocytes.
at day 6 (P  0.001 vs. control). The number of cells
that adhered to tissue culture plates remained significant
when obtained from the urine of PHN rats at day 10
(P 0.001 vs. control) and day 20 (P 0.001 vs. control)
(Fig. 5). These results show that viable cells were de-
tected in the urine of rats from day 5 following the in-
duction of experimental membranous nephropathy and
this peaked on day 6 of disease and decreased at days
10 and 30.
Viable cells in the urine from PHN rats are podocytes
To identify which cell types were present in the urine
and to determine which cell type(s) obtained from the
urine were viable ex vivo, we performed immunostaining
with podocyte, mesangial, endothelial, and tubular cell
specific antibodies, and RT-PCR for immunostains that
were positive.
Figure 6 shows that all adherent cells stained posi-
tively, and abundantly, for the podocyte-specific proteins
podocin, nephrin, and GLEPP1. Cells also stained posi-
tively for synaptopodin, albeit more weakly than the
other podocyte antigens shown in Figure 6. Rat mesan-
gial cell cultures were used as negative controls (results
not shown). Although immunostaining for WT-1 was
detected in cells prior to plating them in culture, we were
unable to detect positive immunostaining for WT-1 in
podocytes growing ex vivo in culture.
We were unable to harvest sufficient protein from ad-
herent cells to perform Western blot analysis. Accord-
ingly, we performed RT-PCR on adherent cells for podo-
cyte-specific antigens, and the results are shown in Figure
7. When total RNA was extracted from adherent cells
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Fig. 7. mRNA expression for podocyte-specific
antigens in cells growing ex vivo. Reverse tran-
scription-polymerase chain reaction (RT-PCR)
was performed on total RNA extracted from
cells growing ex vivo from PHN rats that had
adhered to cell culture plates. mRNA expres-
sion was detected for WT-1, GLEPP1, and po-
docin, but not for nephrin and synaptopodin
(synapo). The absence of transcripts were not
false negatives, because the primers used de-
tected nephrin and synaptopodin mRNA from
normal rat kidney, used as a positive control.
The negative control for each reaction com-
prised omitting the RT product and substitut-
ing this with water.
obtained from PHN rats, mRNA expression was de-
tected for WT-1, GLEPP1, and podocin. In contrast,
mRNA expression was not detected for nephrin and
synaptopodin. These results were not false negatives,
because mRNA expression for nephrin and synapto-
podin were readily detected in RNA extracted from nor-
mal and PHN rat kidneys, used as positive controls.
Staining was also performed with antibodies to well-
defined antigens on other renal cell types in control and
PHN rats. Our results showed no detectable staining for
Thy1 (mesangial cell antigen), RECA-1 (marker specific
for glomerular endothelial cells), Tamm-Horsfall protein
(marker of the thick ascending limb) and Tetragonolobus
purpureas lectin (proximal tubular cell marker) in urine
cultures from control and PHN rats (results not shown).
The absence of immunostaining for these antigens was
not due to the fixative or antibody used, because frozen
rat kidney biopsies fixed similarly to cultured cells stained
positive for each antibody (data not shown).
These results, summarized in Table 1, show that cells
obtained from urine that adhered to cell culture plates
expressed many podocyte-specific proteins, consistent
with the hypothesis that viable podocytes detach in ex-
perimental membranous nephropathy.
Adherent cells have processes ex vivo
In addition to detecting the mRNA and protein expres-
sion of specific cell type markers, cell morphology was
assessed serially by light and electron microscopy (Fig. 8).
A number of observations were made. First, 28  5%
of urinary cells from PHN rats were polyploid. Second,
beginning at day 3, morphologic changes included retrac-
tion of the cytoplasm from the cell periphery and thick-
ening of the cell margins. This coincided with the appear-
ance of cellular compartmentalization into a cell body,
major processes, and minor processes. This was quite
reminiscent of the typical in vivo podocyte architecture
(Fig. 8F). Cell brush borders, characteristic of tubular
cells, were not detected on electron microscopy. Taken
together with the immunostaining data described above,
the electron microscopy suggests that the cells obtained
from the urine of PHN rats are podocytes.
Detached podocytes proliferate ex vivo
We counted cell numbers every 12 hours in cells grow-
ing ex vivo from PHN rats and the results are shown in
Figure 9 (the results from control rats are not reported
because no adherent cells were detected at any of the
time points studied). During the first 4 days of growing
ex vivo, cell number increased every 12 hours under cell
culture conditions, with the peak in cell number occur-
ring at day 4. However, cell number decreased after
day 4, and this coincided with an increase in the number
of apoptotic cells (see below) (Fig. 9). Figure 8 provides
further documentation of cell division in podocytes
grown ex vivo, where cytokinesis was frequently observed.
Shown is a quadronucleated cell undergoing cytokinesis
resulting in two binucleated cells.
These results show that cells present in the urine of rats
with experimental membranous nephropathy increased in
number when grown under tissue culture conditions ex
vivo, consistent with an increase in proliferation.
We determined if the decrease in cell number occur-
ring from day 4 ex vivo was due to apoptosis, and the
results are shown in Figure 9. The first increase in apopto-
sis was detected at 72 hours and persisted thereafter.
These results show that cells derived from urine prolifer-
ate in culture, but the increase in cell number is limited
by an increase in apoptosis.
Podocytes in urine from PHN rats stain positive
for C5b-9
Podocyte injury in membranous nephropathy is due
to C5b-9. Finally, in order to determine if detached podo-
cytes expressed C5b-9, we performed immunostaining
to C5b-9. All cells in the urine from PHN rats stained
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Fig. 8. Cell division in an individual multinucleated cell. (A to F ) A temporal sequence of phase microscopy every 12 hours of a multinucleated
cell dividing under cell culture conditions. Seen is a quadronucleated cell undergoing cytokinesis. Cytokinesis is followed by an increase in cell
size and the development of a cell body with primary and secondary processes. Magnification of processes is shown by electron microscopy.
Fig. 9. Change of cell number and increase in apoptosis over time.
Podocyte colonies were circled and individual cells counted all 12 hours.
A peak of cell number is reached at around 72 hours. Decrease in cell
number timely correlates with the appearance of apoptotic cells.
positive for C5b-9 (Fig. 2F). In contrast, cells from con-
trol rats were not detected.
DISCUSSION
Previous studies have demonstrated that the decrease
in podocyte number is a critical determinant contributing
to the development of glomerulosclerosis in diseases
characterized by podocyte injury, such as membranous
nephropathy [3, 4, 9]. However, the mechanisms underly-
ing podocyte loss remains to be fully elucidated. In this
study, we show that podocytes are present in the urine of
rats with experimental membranous nephropathy (PHN
model) and that once they are detached from the glomer-
ular basement membrane into the urinary space, they
adhere to tissue culture plates ex vivo, indicating that
they are viable.
Cells in the urine are not a novel observation. Studies
three decades ago described the presence of cells in
urine, and the authors interpreted these to be of tubular
origin [24–28]. More recently, several groups have taken
advantage of newer methodologies to document the
presence of urinary podocytes in experimental and hu-
man glomerular disease [9, 17, 29,30]. However, the via-
bility of these cells was not determined, and their prolif-
erative capacity ex vivo has not been assessed. We began
by showing for the first time that cells that express podo-
cyte-specific antigens by immunostaining and RT-PCR
are detected in the urine of rats with the PHN model
of membranous nephropathy, but not in controls. The
immunostaining and RT-PCR results were concordant.
To determine if these cells were viable, cells were plated
onto tissue culture plates and grown under cell culture
conditions.
The major finding in the current study was that cells
obtained from PHN rats adhered to cell culture plates,
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and that they grew ex vivo under cell culture conditions.
Moreover, using cell type specific antibodies, RT-PCR,
and morphologic criteria, our results showed that the
cells growing ex vivo were podocytes. These data show
that podocytes in the urine of PHN rats were viable. We
did observe some discrepancy between the immunostain-
ing and RT-PCR results for WT-1, nephrin, and synapto-
podin in adherent cells. First, despite abundant nephrin
immunostaining in adherent cells, nephrin mRNA ex-
pression was not detected in these cells. Of note, nephrin
mRNA was detected in cells obtained from PHN rat urine
prior to being grown in culture (Fig. 3). Second, although
synaptopodin immunostaining was barely detected in ad-
herent cells, no mRNA expression was detected from
adherent cells, despite the mRNA expression being de-
tected when cells from the urine of PHN rats were stud-
ied prior to being committed to cell culture conditions.
Finally, WT-1 immunostaining was positive in cells prior
to the cell culture conditions, but was not detected once
the cells adhered. In contrast, the mRNA expression
that was detected prior to cell culture plating persisted
in adherent cells. The reasons for these alterations in
immunostaining are not known. One can speculate that
we did not examine the correct time points or that the
protein expression is altered ex vivo. Also, different regu-
latory mechanisms, including transcription and translation,
might contribute.
In contrast to the presence of podocyte-specific anti-
gens, we did not detect positive immunostaining for mes-
angial, endothelial, and tubular cell antigens. Although
these cell types may have been present at low concentra-
tions initially, the cell culture conditions selective for
podocytes may favor podocyte growth over other cells.
The final result was cell cultures uniformly staining posi-
tively for podocyte-specific proteins.
We asked if the loss of viable podocytes persisted
throughout the course of disease. Our results also showed
that loss of viable podocytes was present from day 5 of
PHN, and that podocyte loss was ongoing up to day 20
of study in PHN rats. These results suggest that viable
podocyte loss is ongoing. The consequence of this may
be linked with podocyte number in PHN rats, because
our data showed that there was a progressive decrease
in podocyte number in PHN rats, which did not occur in
controls. This decrease in glomerular podocyte number
correlated with an increase in proteinuria at later time
points. Thus, detachment of viable podocytes may be
one explanation for the decrease in podocyte number.
We did not examine the mechanisms underlying the de-
tachment of viable podocytes. One may speculate a role
for specific integrins, dystrophins, and other cellular
events, which are currently under study.
A fundamental question is the proliferative capacity
of podocytes. The prevailing notion is that podocytes do
not typically proliferate in vivo [31, 32]. Indeed, studies
have shown that the limited proliferative potential of
podocytes is a major contributor to the development
of progressive glomerulosclerosis [6, 33]. A variety of
potential mechanisms have been shown to limit podocyte
proliferation in vivo, including an increase in specific
cell cycle inhibitors. We and others have shown that
podocytes increase cell cycle proteins required for DNA
synthesis [7] and mitosis [10, 34]. Yet, there is a belief
that podocytes do not divide (cytokinesis) in vivo in
experimental and human membranous nephropathy.
The results of the current study may shed new light into
our understanding of podocyte proliferation. Our data
showed that once viable podocytes from PHN rats are
grown ex vivo, they increase in number during the first
60 hours of culture. These results suggest that when
podocytes are no longer adherent to the glomerular base-
ment membrane in vivo, they have the capacity to prolif-
erate. This raises the possibility that podocyte attach-
ment to the underlying glomerular basement membrane
may be a limiting factor in this cell’s proliferative capac-
ity. Studies are needed to elucidate the mechanisms of
podocyte proliferation ex vivo.
Despite proliferation ex vivo, cell number decreased
with time due to increased apoptosis. It is unclear if the
switch from a predominantly proliferative phenotype to
an apoptotic one is due to the cell culture conditions,
the cells limited proliferative capacity (such as occurs in
vivo), or the loss of survival factors. Finally, because a
large number of podocytes were bi- and multinucleated
in vitro (similar to that described in vivo in PHN rats)
[35], another possibility is that only polyploid cells are
able to complete cytokinesis ex vivo, and thus proliferate,
and that polyploid cells are the phenotype primarily lost
in the urine.
What are the clinical implications of our study? One
possibility is that detecting viable podocytes in urine may
assist with the diagnosis of diseases of the podocyte.
Second, we showed that podocytes from PHN rats
stained positive for C5b-9. This finding is specific to mem-
branous nephropathy and might assist with a prebiopsy
diagnosis. One other potential application is the detec-
tion of gene product defects, such as nephrin or podocin,
in patients with congenital diseases.
CONCLUSION
This study shows that podocytes detach in experimen-
tal membranous nephropathy and are viable. They also
have a limited proliferative capacity ex vivo, before un-
dergoing apoptosis. Further studies are needed to delin-
eate the mechanisms underlying podocyte detachment
and to determine if attachment to the glomerular base-
ment membrane limits proliferation.
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